The National Ethical Guidelines and Research on Bromocriptine
Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2018, Vol 17, Issue 11
Abstract
Bromocriptine reduces growth hormone secretion in Acromegaly. It is also effective in Parkinson disease. It is open labeled study. Single dose administration of 2.5mg Bromocriptine mesylate to patients 3 and 5 healthy volunteers to fasted condition. AUC observed normal.
Authors and Affiliations
K. Jyothsna, G. Vijayalakshmi
Effectiveness of Early Clinical Exposure in First M.B.B.S Students
Back ground: Early clinical exposure ensures more knowledge about basic sciences, clinical sciences and patient – doctor interactions. Present study was planned to study the impact of early clinical exposure in the knowl...
Lipid Profile In Thalassemia Patients Common In Eastern India And It’s Correlation With Erythroid Bone Marrow Activity
Introduction Lipid abnormalities, including low levels of all fractions of serum lipids have been repeatedly reported in all phenotypes of Beta- thalassemia patients. In the present study, the low lipid profile of variou...
KAP of Antibiotic Resistance among the Junior Doctors in RIMS
Introduction: WHO Defines The Appropriate Use Of Antimicrobials As “The Cost Effective Use Of Antimicrobials Which Maximizes Clinical Therapeutic Effect While Minimizing Both Drug-Related Toxicity And The Development Of...
Qsar And Synthesis Of Curcumin Analogues As Antibacterial
This study was aimed to analyze the Quantitative Structure-Activity Relationship (QSAR) of antibacterial activity between 37 curcumin analog compounds against S. aureus, B. subtilis and K. pneumoniae. The new compound wa...
Contemporary Issues in Single Versus Multiple Visits in Endodontics: A Review
There have been a number of controversies in endodontics some solved, some abandoned, some remaining. It is not to be expected that within a foreseeable future there will be rapid solutions to the issues reviewed here. T...